INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $211,546 | -0.5% | 5,188 | -12.1% | 0.05% | -8.9% |
| Q1 2023 | $212,518 | +1.5% | 5,900 | -1.7% | 0.06% | +1.8% |
| Q4 2022 | $209,340 | -37.7% | 6,000 | 0.0% | 0.06% | -45.0% |
| Q3 2022 | $336,000 | -8.2% | 6,000 | +6.2% | 0.10% | +7.5% |
| Q2 2022 | $366,000 | -3.2% | 5,650 | +8.7% | 0.09% | +3.3% |
| Q1 2022 | $378,000 | -35.4% | 5,200 | +5.1% | 0.09% | -46.1% |
| Q4 2021 | $585,000 | -4.1% | 4,950 | +8.8% | 0.17% | -16.5% |
| Q3 2021 | $610,000 | -17.2% | 4,550 | 0.0% | 0.20% | -18.7% |
| Q2 2021 | $737,000 | +101.9% | 4,550 | 0.0% | 0.25% | +75.7% |
| Q1 2021 | $365,000 | +47.2% | 4,550 | 0.0% | 0.14% | +6.1% |
| Q4 2020 | $248,000 | – | 4,550 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |